Back to search

Article

Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence

2019-06-11

Abstract excerpt

<h4>Background</h4> The oncogene LSF (encoded by TFCP2 ) has been proposed as a novel therapeutic target for multiple cancers. LSF overexpression in patient tumors correlates with poor prognosis in particular for both hepatocellular carcinoma and colorectal cancer. The limited treatment outcomes for these diseases underscore the need for molecularly targeting novel mechanisms. LSF small molecule inhibitors, Fact...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a658fa8f-0b28-515f-b54e-d9b9d47d3784
DOI
10.1101/665570
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescenceDOI 10.1101/665570
Select a neighboring publication to make it the new centre.